I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

It is estimated that depression often interferes with treatment of medical conditions, largely due to nonadherence to medical recommendations.\[[@ref1]\] This may result in serious medical complications.\[[@ref2]\] Studies report between 20% and 48% of heart failure (HF) patients who experience depression\[[@ref3]\] which adversely affects their quality of life,\[[@ref4]\] produces uncertain treatment outcomes,\[[@ref5]\] and leads to increased service utilization/hospital re-admissions and premature mortality.\[[@ref6][@ref7]\]

While only 14% of Medicare patients have HF, they consume approximately 43% of annual Medicare spending.\[[@ref8]\] Evidence suggests that compared to nondepressed patients, depression among HF patients adds between 30% and 48% to their hospital cost,\[[@ref9][@ref10]\] but data according to ethnicity are sparse. This paper examines two-related issues by ethnicity and gender among California patients: (i) prevalence of depression and HF and (ii) depression effects on HF cost within each ethnic/gender group by comparing HF patients with depression (HF^+D^) patients with HF without depression (HF^ND^) patients.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Sample and data characteristics {#sec2-1}
-------------------------------

Hospital Discharge Data files are administrative files that provide patients\' basic demographics along with the International Classification of Diseases, Ninth Revision (ICD-9) diagnostic codes (both primary and secondary) for each hospital discharge. Data from licensed general acute care facilities of California were obtained from the California\'s Office of Statewide Health Planning and Development for the year 2010. A total of 62,685 patients (aged 20+) with a primary diagnosis of HF (ICD-9 codes 402,404,428) along with their demographics, diagnoses of depression and anxiety, length of stay, and charges for each discharge were analyzed.

Since 48%--91% of symptoms overlap between depression and anxiety,\[[@ref11][@ref12]\] we combined them as a single variable of depression for analyses. Two indices of comorbidities were computed: (i) a simple count of all secondary diagnoses as comorbidities that were identified by ICD-9-Clinical Modification codes for each patient and (ii) Charlson index of comorbidity,\[[@ref13]\] which measures severity of comorbidity for each patient. Further, two types of hospital costs were developed: (i) costs for HF alone (HF cost \$) when a patient was discharged with a primary diagnosis of HF and (ii) total hospital cost for the year 2010 (total cost \$), that is, when the same patient was discharged with diagnoses other than HF.

Statistical analysis {#sec2-2}
--------------------

Age-adjusted HF rates per 100,000 adults (2010 Census) were developed per Center for Disease Control and Prevention (CDC) methodology.\[[@ref14]\] The prevalence of HF and risk factors by race/ethnicity and age were all evaluated with Pearson\'s Chi-square and Fisher\'s exact tests. Cost differences between groups were evaluated with ANOVA.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Prevalence of depression and heart failure by ethnicity and gender {#sec2-3}
------------------------------------------------------------------

[Table 1](#T1){ref-type="table"} provides details regarding the prevalence and distribution of HF, depression, and comorbidities. Overall prevalence of HF was 255.5/100,000 and the rates were higher (*P* \< 0.001) among males compared to females (313.1 vs. 223.4), highest (*P* \< 0.001) among blacks (617.9), and least among Asians/Pacific Islanders (AP) (189.6). Depression was more prevalent among HF patients than non-HF patients (21% vs. 15%, *P* \< 0.001). Further, among HF patients, depression was also higher among females than males (25% vs. 16%, *P* \< 0.001) and higher (*P* \< 0.001) among whites (33%) than other groups. Compared to non-HF patients, HF patients were older in age (73 vs. 66 years) and had more comorbidities (3.92 vs. 2.68, *P* \< 0.001).
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Overall heart failure hospital cost and effect of depression {#sec2-4}
------------------------------------------------------------

Hospital costs are affected by numerous factors including severity of medical condition (as measured by Charlson index of severity), number of comorbidities, number of hospital admissions, length of stay, and treatment procedures provided to the patients. [Table 1](#T1){ref-type="table"} shows that the average cost per patient of HF alone was \$77,417 and total cost for the year was 45% higher among HF patients compared to non-HF patients (\$150,500 vs. \$94,811). Further, among the HF patients, both HF cost alone and the total costs for the year were higher (*P* \< 0.001) for males (\$83,564 and \$158,050) than females (\$71,106 and \$142,740). The higher costs among males were largely due to greater number and severity of the comorbidities. Further, HF cost as well as the total cost varied by ethnicity in that both costs were higher (*P* \< 0.001) for AP (\$83,469 and \$165,960, respectively), compared to other ethnic groups including blacks (\$82,929 and \$165,390), Hispanics (\$80,981 and \$158,360), and whites (\$73,985 and \$141,980). It may be noted that in all groups, HF cost alone added 50% to their total cost that year.

The effect of depression on hospital costs varied substantially by ethnicity and gender. [Table 2](#T2){ref-type="table"} shows that the cost of HF^+D^ patients was 22% higher compared to HF^ND^ patients (\$91,880 vs. \$73,667). In fact, the higher costs for HF^+D^ patients existed across all ethnic and gender groups with some variation. For example, black HF^+D^ cost was 45% higher compared to nondepressed black HF^ND^ patients (\$119,340 vs. \$75,358), followed by 21% among whites (\$86,466 vs. \$70,252), Hispanics 18% (\$93,627 vs. \$77,870), and AP who had the lowest (14%) cost difference (\$94,326 vs. \$82,034). Further, the cost for HF^+D^ males was 33% higher compared to HF^ND^ males (\$109,160 vs. \$78,568). Similar higher depression cost amounting to 17% also existed among HF^+D^ females compared to HF^ND^ females (\$80,273 vs. \$68,057). These data clearly indicate that depression increases cost of hospitalization significantly regardless of the patient\'s gender or ethnicity.
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D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

HF is a leading cause of hospital admissions among the elderly in the United States and as such represents a great cost burden. Since patients with moderate-to-severe depression transit faster from a healthy state to HF,\[[@ref8]\] their risk of developing HF is estimated to increase by 40%.\[[@ref15]\] Our analyses show that costs for both HF and HF^+D^ patients are high compared to those without such clinical condition. Further, these costs were higher among minority patients and men. Further research is needed to examine other factors that may contribute to gender differences in hospital costs.

While one-fifth of our patients were depressed, their depression added 22% to their hospital cost. Depression is known to increase health-care costs\[[@ref15]\] along with other comorbidities that may increase hospitalization. However, our cost estimates are probably underestimates, in part, because of underdiagnosis. Future research should estimate the cost-effectiveness of screening and proper treatment of depression among HF patients.

Finally, minority HF patients had numerous notable comorbidities, such as hypertension, diabetes, and chronic kidney disease. The high prevalence of these medical disorders, particularly among males and underserved groups, underscores the use of both evidence-based preventive programs and optimal therapy to reduce costly hospitalization. Further reduction in HF hospitalization may be attained through coordination of community-based resources for HF patients with complex conditions.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

Studies are needed to examine whether higher HF hospital costs could be reduced by:

Screening and treating depression along HF symptoms andImplementing community-wide proven preventive programs pertaining to hypertension and diabetes to reduce HF prevalence
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